Alzheimer's drug developer Probiodrug, the backers of which include Biogen Idec, has set the range for a proposed initial public offering in the Netherlands.

Tencent Holdings has made the largest single investment in China's Internet healthcare sector, investing more than $100m in online medical service provider GuaHao.com.

Intrexon plans to invest $15m in the tissue implant developer as part of its initial public offering, which will support its product candidate through Phase 3 trials.

Invitae, originally formed as a subsidiary of Genomic Health, has now raised more than $200m as it looks to expand across the globe.

Life sciences company Great Basin, which closed a $7.6m series D round featuring Hitachi Chemical in April, has raised more than $8m from its initial public offering.

BioHealth Gap fund will target early-stage companies in Maryland.

Leiden spin-out Mimetas secures investment from Dutch venture capitalists.

Qbic Arkiv Fund, Foundation Majoie and Sofi invest in the Ghent University spin-out.

ASU spin-out Thync secures funding from Khosla Ventures.